Healthcare services spark Fonar sales
It’s becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company
Its becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company reporting a 34% increase in second-quarter revenues at the same time that its scanner business remained in the doldrums.
For the period (end-December), Fonar reported sales of $9.1 million, compared with revenues of $6.8 million in the same period of 1998. The companys net loss for the quarter was $2.5 million, compared with a net loss of $2.1 million in the second quarter of fiscal 1998.
Health Management Corporation of America, Fonars physician practice management subsidiary, was the engine behind the companys revenue growth. Meanwhile, sales of Fonars Quad products amounted to only $602,000 for the quarter, compared with $1 million in the same period a year ago. Fonar believes that its new scanners, such as Open Sky MRI and Stand-Up MRI, will lead to sales growth when they begin shipping.
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
